Arvind Singh Mer

8PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersModelling and simulationGenomics and transcriptomicsMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 16, 2026
A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer.

|Jun 10, 2026
Artificial intelligence-enabled histological analysis in pre-clinical respiratory disease models: a scoping review.

|Apr 12, 2024
Text-mining-based feature selection for anticancer drug response prediction.

Grace Wu, Arvin Zaker, Amirhosein Ebrahimi

|May 10, 2022
Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity.

Wail Ba-Alawi, Sisira Kadambat Nair, Bo Li

|Dec 16, 2021
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.

Chewei Anderson Chang, Jayu Jen, Shaowen Jiang

|Nov 17, 2021
Assessing therapy response in patient-derived xenografts.

Janosch Ortmann, Ladislav Rampášek, Elijah Tai

Pageof 2

Frequent Collaborators

5 joint publications

Benjamin Haibe-Kains

2 joint publications

Aaron D Schimmer

2 joint publications

David W Cescon

1 joint publications

Prarthna Karunamurthy